Detalhe da pesquisa
1.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666013
2.
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Diabetes Obes Metab
; 23(10): 2336-2343, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212481
3.
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(8): 1956-1960, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852196
4.
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
J Diabetes Complications
; 35(12): 108077, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686406
5.
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
Diabetes Res Clin Pract
; 178: 108947, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252505
6.
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
ESC Heart Fail
; 8(2): 1711-1716, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570253